

Sensible Medicine
Sensible Medicine Authors and Editors
Common sense and original thinking in bio-medicine
A platform for diverse views and debate www.sensible-med.com
A platform for diverse views and debate www.sensible-med.com
Episodes
Mentioned books

13 snips
Mar 24, 2026 • 40min
This Fortnight in Medicine XXII
A lively debate about GLP‑1 drugs and whether observational VA data can really link them to substance use outcomes. A deep dive into timing and scope of PCI for heart attacks, questioning complete revascularization versus treating only the culprit lesion. Discussion about trial design, confounding, and risks of extra procedures. Clinical caution and calls for randomized trials run through the conversation.

Mar 11, 2026 • 36min
This Fortnight in Medicine XXI
They discuss controversies around how fast to correct severe hyponatremia and limitations of observational data versus randomized trials. They debate designing pragmatic trials to compare correction strategies. They explore a cluster trial of neuromuscular warm-ups in urban high school girls and whether prevention programs can reduce ACL injuries.

9 snips
Mar 4, 2026 • 24min
Going Beyond "AI in Medicine"
Dr. Shantanu Nundy, a practicing physician, innovator, FDA AI advisor, and author. He explores using AI to raise care for underserved populations. He outlines autonomous AI clinicians, multimodal early screening, and AI-generated drug endpoints. He discusses AI as a behavior-change coach, monitoring signals beyond vitals, and breaking care into micro use-cases with an AI team.

Feb 25, 2026 • 39min
This Fortnight in Medicine XX
Discussion of high-dose versus standard-dose influenza vaccines for older adults, focusing on hospitalization outcomes and low event rates. Debate over public health value, cost, and regulatory issues around mRNA flu comparators. Review of beta blocker use after myocardial infarction in patients with preserved ejection fraction, including a surprising signal suggesting harm in women and whether that finding is real.

10 snips
Feb 18, 2026 • 37min
Alternative Modalities for Breast Cancer Screening
Dr. Jennifer Rusiecki, Associate Professor of Medicine at the University of Chicago and director of women’s health in residency, talks about breast density and screening. She explains why density causes confusing warning letters. She reviews supplemental options like 3D mammography, whole-breast ultrasound, MRI and contrast-enhanced mammography. She also addresses stratified screening, prevention, and counseling approaches.

Feb 11, 2026 • 45min
This Fortnight in Medicine XIX
They debate a trial that tested scheduled versus as‑needed dialysis for acute kidney injury and question how enrollment and ICU focus affect results. They examine a patient‑level meta‑analysis on beta blockers after heart attack in people with normal pumping function. They argue about whether older evidence still applies and the practical tradeoffs of using less treatment.

Jan 28, 2026 • 46min
This Fortnight in Medicine XVIII
They debate a new flu antiviral, covering trial results, timing of treatment, household transmission, costs, and comparisons with older drugs. They dig into a heart failure trial about rapid medication up-titration, questioning follow-up intensity, patient selection, and real-world applicability. The conversation centers on tradeoffs between pragmatic trials and individualized clinical care.

Jan 23, 2026 • 7min
Friday Reflection 56: Comments that Stuck
Short reflections on a few offhand comments that shaped bedside manner and clinical choices. Stories include an elderly patient arriving late during a snowstorm and a decision to still see her. Anecdotes range from grocery-store lessons about practicality to caring for immigrant patients and learning who you can and cannot be for every person.

4 snips
Jan 18, 2026 • 40min
When to treat (or not treat) a high cholesterol
Venk Murthy, a cardiologist from the University of Michigan, and Andrew Foy, a preventive cardiology specialist, dive into the complexities of cholesterol management. They challenge the standard thresholds for treating high LDL, emphasizing the importance of overall risk assessment. Venk discusses genetic insights suggesting earlier LDL lowering, while Andrew highlights the nuanced decision-making required for treating isolated LDL elevations. They also debate when to incorporate coronary calcium scoring and the limitations of relying solely on lifelong prevention strategies.

Jan 14, 2026 • 45min
This Fortnight in Medicine XVII
Medical Management and Revascularization for Asymptomatic Carotid StenosisVagus nerve-mediated neuroimmune modulation for rheumatoid arthritis: a pivotal randomized controlled trialWe spent quite a bit of time talking about blinding. This is the table on the adequacy of blinding from the supplement. It does seem like blinding was less than perfect. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.sensible-med.com/subscribe


